12-10997760-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_176889.4(TAS2R20):āc.116A>Gā(p.Gln39Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176889.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R20 | NM_176889.4 | c.116A>G | p.Gln39Arg | missense_variant | 1/1 | ENST00000538986.2 | NP_795370.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R20 | ENST00000538986.2 | c.116A>G | p.Gln39Arg | missense_variant | 1/1 | 6 | NM_176889.4 | ENSP00000441624.1 | ||
ENSG00000275778 | ENST00000703543.1 | c.-125-24039A>G | intron_variant | ENSP00000515364.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000959 AC: 24AN: 250258Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135386
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461648Hom.: 0 Cov.: 34 AF XY: 0.0000248 AC XY: 18AN XY: 727106
GnomAD4 genome AF: 0.000263 AC: 40AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.116A>G (p.Q39R) alteration is located in exon 1 (coding exon 1) of the TAS2R20 gene. This alteration results from a A to G substitution at nucleotide position 116, causing the glutamine (Q) at amino acid position 39 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at